InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
1
T+90 hit rate
60%
T+90 mean return
-7.9%
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by LANGER DENNIS, Director. Director active across 3 companies, notably Myriad Genetics INC. Cumulatively, 7 disclosures have been recorded. Breakdown: 0 buy · 1 sell. Total volume traded: €200. History available since 3 June 2021. The latest transaction was filed on 7 June 2024 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations7 total
297 shares@ US$0.732100.0% of flowOrdinary SharesSEC:0001104659-24-070017:0
17,275 shares0Common StockSEC:0001628280-22-016225:0
30,000 shares@ US$25.390.19% mcap50.0% of flowCommon StockSEC:0001274225-21-000004:0
30,000 shares@ US$25.3950.0% of flowCommon StockSEC:0001274225-21-000004
12,848 shares0Common StockSEC:0001274225-21-000002:0
12,848 shares0Common StockSEC:0001274225-21-000002
34,722 sharesCommon StockSEC:0000899243-16-012748:0
7 of 7 declarations
About LANGER DENNIS
Dennis Langer is a Director at Myriad Genetics Inc. In this role, he contributes to corporate governance and the company's strategy. His experience in the life sciences sector allows him to provide valuable insights to strategic discussions within the board.
